Association of Serum P-Cresyl Sulfate Level with Peripheral Artery Disease in Kidney Transplantation Patients

Hsiao-Hui Yang1,2,3, Yen-Cheng Chen1,2, Chin-Hung Liu4,5

  • 1Division of General Surgery, Department of Surgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan.

Insights

Higher levels of the uremic toxin p-cresyl sulfate (PCS) are linked to peripheral artery disease (PAD) in kidney transplant (KT) recipients. This suggests residual toxin burden impacts vascular health post-transplant.

Area of Science:

  • Nephrology
  • Vascular Biology
  • Toxicology

Background:

  • p-Cresyl sulfate (PCS) is implicated in endothelial dysfunction and vascular remodeling.
  • Peripheral artery disease (PAD), indicated by a low ankle-brachial index (ABI), is a significant mortality risk in kidney transplant (KT) recipients.

Purpose of the Study:

  • To investigate the association between serum PCS levels and PAD in KT recipients.
  • To determine if PCS is an independent predictor of PAD in this population.

Main Methods:

  • A cross-sectional study of 90 KT recipients.
  • Serum PCS quantified by liquid chromatography-mass spectrometry.
  • PAD defined as ABI < 0.9, measured via automated oscillometric device.

Main Results:

  • 22.2% of KT recipients had PAD.
  • PAD patients showed higher prevalence of diabetes and elevated serum PCS levels (p=0.001).
  • Serum PCS levels were independently associated with PAD (OR 1.254, p<0.001) and inversely correlated with ABI.

Conclusions:

  • Elevated serum PCS levels are independently associated with PAD in KT recipients.
  • Residual uremic toxin burden may contribute to peripheral vascular disease post-KT.
  • PCS may be a therapeutic target for preventing vascular complications in KT recipients.

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...